These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 16707471

  • 21. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.
    Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M, Bronte V, Pericle F.
    Cancer Res; 2001 Feb 01; 61(3):859-63. PubMed ID: 11221870
    [Abstract] [Full Text] [Related]

  • 22. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S, Bartholomew RM, Pezzoli P, Gutierrez A, Gouveia E, Bassett D, Soo Hoo W, Carlo DJ.
    Gene Ther; 2002 Oct 01; 9(19):1302-11. PubMed ID: 12224013
    [Abstract] [Full Text] [Related]

  • 23. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
    Yamano T, Kaneda Y, Huang S, Hiramatsu SH, Hoon DS.
    Mol Ther; 2006 Jan 01; 13(1):194-202. PubMed ID: 16112911
    [Abstract] [Full Text] [Related]

  • 24. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.
    Steitz J, Büchs S, Tormo D, Ferrer A, Wenzel J, Huber C, Wölfel T, Barbacid M, Malumbres M, Tüting T.
    Int J Cancer; 2006 Jan 15; 118(2):373-80. PubMed ID: 16049960
    [Abstract] [Full Text] [Related]

  • 26. Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
    Gaffal E, Landsberg J, Bald T, Sporleder A, Kohlmeyer J, Tüting T.
    Int J Cancer; 2011 Jul 15; 129(2):285-94. PubMed ID: 21207411
    [Abstract] [Full Text] [Related]

  • 27. Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen.
    Bridle BW, Li J, Jiang S, Chang R, Lichty BD, Bramson JL, Wan Y.
    J Immunol; 2010 Apr 15; 184(8):4269-75. PubMed ID: 20237288
    [Abstract] [Full Text] [Related]

  • 28. High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.
    Grinshtein N, Ventresca M, Margl R, Bernard D, Yang TC, Millar JB, Hummel J, Beermann F, Wan Y, Bramson JL.
    Cancer Gene Ther; 2009 Apr 15; 16(4):338-50. PubMed ID: 18989352
    [Abstract] [Full Text] [Related]

  • 29. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
    Li H, Ou X, Xiong J.
    Gynecol Oncol; 2007 Mar 15; 104(3):564-71. PubMed ID: 17081598
    [Abstract] [Full Text] [Related]

  • 30. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
    Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D.
    Gene Ther; 1999 Oct 15; 6(10):1768-73. PubMed ID: 10516727
    [Abstract] [Full Text] [Related]

  • 31. Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity.
    Tada Y, O-Wang J, Wada A, Takiguchi Y, Tatsumi K, Kuriyama T, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2003 Feb 15; 10(2):134-40. PubMed ID: 12536202
    [Abstract] [Full Text] [Related]

  • 32. Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity.
    Steitz J, Brück J, Gambotto A, Knop J, Tüting T.
    Gene Ther; 2002 Feb 15; 9(3):208-13. PubMed ID: 11859424
    [Abstract] [Full Text] [Related]

  • 33. Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice.
    Hacker E, Muller HK, Irwin N, Gabrielli B, Lincoln D, Pavey S, Powell MB, Malumbres M, Barbacid M, Hayward N, Walker G.
    Cancer Res; 2006 Mar 15; 66(6):2946-52. PubMed ID: 16540642
    [Abstract] [Full Text] [Related]

  • 34. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM, Li Y, Chiou KC, Chan B, Rizzuto G, Terzulli SL, Merghoub T, Houghton AN, Wolchok JD.
    Cancer Res; 2008 Dec 01; 68(23):9884-91. PubMed ID: 19047169
    [Abstract] [Full Text] [Related]

  • 35. Neoadjuvant vaccination provides superior protection against tumor relapse following surgery compared with adjuvant vaccination.
    Grinshtein N, Bridle B, Wan Y, Bramson JL.
    Cancer Res; 2009 May 01; 69(9):3979-85. PubMed ID: 19383917
    [Abstract] [Full Text] [Related]

  • 36. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines.
    Cho EI, Tan C, Koski GK, Cohen PA, Shu S, Lee WT.
    Head Neck; 2010 Jun 01; 32(6):700-7. PubMed ID: 19908319
    [Abstract] [Full Text] [Related]

  • 37. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.
    Perricone MA, Claussen KA, Smith KA, Kaplan JM, Piraino S, Shankara S, Roberts BL.
    Mol Ther; 2000 Mar 01; 1(3):275-84. PubMed ID: 10933943
    [Abstract] [Full Text] [Related]

  • 38. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ.
    Vaccine; 2007 Jan 08; 25(4):763-75. PubMed ID: 16968658
    [Abstract] [Full Text] [Related]

  • 39. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 08; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice.
    Song S, Wang F, He X, He Y, Li D, Sun S.
    Vaccine; 2007 Jun 15; 25(25):4853-60. PubMed ID: 17418455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.